PRE 14A

PROXY STATEMENT

Company: NRX Pharmaceuticals, Inc.
Filed: October 29, 2019
Period of Report: November 21, 2019
Accession Number: 0001654954-19-012062

View Document ↗ View on SEC.gov ↗